MK-0646 plus Erlotinib in Recurrent Non-Small Cell Lung Cancer

• Research type

  Research Study

• Full title

  An Open Label, Randomized Phase I/IIa Trial Evaluating MK-0646 in Combination With Erlotinib (TARCEVA™) for Patients With Recurrent Non-Small Cell Lung Cancer

• Contact name

  Elizabeth Ruth Plummer

• Contact email

  Ruth.Plummer@newcastle.ac.uk

• Sponsor organisation

  Merck & Co, Inc.

• Eudract number

  2007-005941-39

• Clinicaltrials.gov Identifier

  NCT00654420

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  08/H0904/90

• Date of REC Opinion

  28 Oct 2008

• REC opinion

  Favourable Opinion